✦ LIBER ✦

5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. final results of a randomised trial in metastatic colorectal cancer

✍ Scribed by Ph. Rougier; B. Paillot; A. LaPlanche; F. Morvan; J.F. Seitz; C. Rekacewicz; P. Laplaige; J. Jacob; S. Grandjouan; J.M. Tigaud; M.C. Fabri; M. Luboinski; M. Ducreux

Book ID: 117663905
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 552 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)00175-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

702 Randomized phase III trial comparing

702 Randomized phase III trial comparing 5FU bolus and low dose leucovorin versus 5FU bolus plus continuous 5FU infusion and high dose LV in metastatic colorectal cancer

✍ J.F. Basset; A. De Grammont; C. Milan; P. Rougier; O. Bouche; P.L. Etienne; F. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Plasma and salivary pharmacokinetics of

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

✍ J.M Joulia; F Pinguet; M Ychou; J Duffour; C Astre; F Bressolle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB

597 ORAL A randomised phase III multicen

597 ORAL A randomised phase III multicenter trial comparing irinotecan in combination with either the Nordic bolus 5FU and folinic acid (5FU/FA) schedule (FLIRI) or the bolus/infused de Gramont schedule (FOLFIRI), in patients with metastatic colorectal cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A phase I trial of 5-day chronomodulated

A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer

✍ C. Garufi; F. Lévi; A.M. Aschelter; R. Pace; S. Giunta; C. Nisticó; D.A.P. Gallà 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 766 KB

Phase III trial of bolus 5-fluorouracil

Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

✍ A. Grothey; T. Buechele; H. Kroening; K. Ridwelski; P. Reichardt; A. Kretzschmar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB